Status:

RECRUITING

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

Lead Sponsor:

M.D. Anderson Cancer Center

Conditions:

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

Eligibility:

All Genders

6-29 years

Phase:

NA

Brief Summary

This clinical trial studies how well an exercise program (Totally Excited About Moving, Mobility, and Exercise \[TEAM Me\]) affects the exercise and dietary habits of pediatric and adolescents and you...

Detailed Description

PRIMARY OBJECTIVE: I. To evaluate the feasibility and tolerability of this exercise program using a token economy system in hospitalized pediatric and adolescent and young adult (AYA) undergoing hema...

Eligibility Criteria

Inclusion

  • Be admitted to an inpatient pediatric ward for the purpose of HSCT for the treatment of malignancy
  • Be greater than or equal to 6 years of age and less than 30 years of age
  • Participants or guardians are willing and able to give written informed consent either prior to admission or within 48 hours following admission and to comply with all of the study activities and procedures
  • Participants or guardians are willing and able to give written informed consent for protocol PA18-0130 (Pediatric Energy balance data repository protocol), companion protocol for the Fitbit application/assessment

Exclusion

  • Patients whose clinical status precludes them from participating in any physical activity including but not limited to: declining respiratory status, hypoxia requiring high flow nasal cannula (Vapotherm), hypotension, and active bleeding.
  • At MD Anderson HSCT patients admitted to adult units for their transplant will not be eligible as TEAM Me is an established program on the G9 Pediatrics Unit only

Key Trial Info

Start Date :

November 13 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04678427

Start Date

November 13 2020

End Date

December 31 2025

Last Update

October 27 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

UT Southwestern/Simmons Cancer Center-Dallas

Dallas, Texas, United States, 75235

2

M D Anderson Cancer Center

Houston, Texas, United States, 77030